Intranasal Atomized Dexmedetomidine in Combination With Intranasal Atomized Butorphanol for Dressing Change Sedation and Analgesia in Adult Burn Patients: A Randomized Clinical Trial
Journal of Burn Care & Research · 2025
DOI: 10.1093/jbcr/irae158 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Burn Care & Research, 2025. Verfasst von Xianchao Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Plastic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China. Hauptthemen laut MEDLINE: Dexmedetomidine, Burns, Butorphanol, Bandages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Zhenjiang Science and Technology Planning.
Abstract (Originalsprache)
We aimed to evaluate the efficacy of the intranasal atomized dexmedetomidine (IAD) + intranasal atomized butorphanol (IAB) combination therapy on adult patients with burns undergoing dressing changes. Herein, 46 adult patients with burns were enrolled and randomly divided into 2 groups: dexmedetomidine-butorphanol (DB) and saline-butorphanol, treated with atomized dexmedetomidine + butorphanol and saline + butorphanol, respectively. The primary outcomes were the Ramsay Sedation Scale (RSS) and the Visual Analog Scale (VAS) scores. The secondary outcomes were mean blood pressure (MBP), heart rate, respiratory rate (RR), peripheral blood oxygen saturation (SpO2), total butorphanol consumption, and adverse effects. The 2 groups were comparable in age, sex, weight, and total burn surface area. During dressing changes, the DB group exhibited significantly lower RSS levels (P < .05). Besides, the 2 groups showed no significant differences in VAS scores across all measurement time points. Notably, the DB group exhibited decreased MBP at the beginning of the operation (P < .0001), 10 min after (P < .0001), and 20 min after (P = .0205). Heart rate decreased significantly at the beginning (P = .0005) and 10 min after (P = .0088) in the DB group. Furthermore, the 2 groups showed no significant differences in RR and SpO2 levels. In addition, the rescue butorphanol dose was lower in the DB group (P < .001). Finally, dizziness and nausea incidences were significantly lower in the DB group (P < .05). In conclusion, besides its hemodynamic adverse reactions, the IAD + IAB combination therapy exerted a better sedation effect in adult patients with burns than IAB treatment alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn and Plastic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China.
- Department of Burn and Plastic Surgery, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, PR China.
ORCID-Profile: Xianchao Ding
Förderung
- Zhenjiang Science and Technology Planning
Zitieren
APA
Ding, X., Shi, D., Cai, H., Yan, Z., & Shen, G. (2025). Intranasal Atomized Dexmedetomidine in Combination With Intranasal Atomized Butorphanol for Dressing Change Sedation and Analgesia in Adult Burn Patients: A Randomized Clinical Trial. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/irae158
Vancouver
Ding X, Shi D, Cai H, Yan Z, Shen G. Intranasal Atomized Dexmedetomidine in Combination With Intranasal Atomized Butorphanol for Dressing Change Sedation and Analgesia in Adult Burn Patients: A Randomized Clinical Trial. Journal of Burn Care & Research. 2025. doi:10.1093/jbcr/irae158
BibTeX
@article{Ding2025,
author = {Ding, Xianchao and Shi, Daoming and Cai, Honghua and Yan, Zhixin and Shen, Guoliang},
title = {Intranasal Atomized Dexmedetomidine in Combination With Intranasal Atomized Butorphanol for Dressing Change Sedation and Analgesia in Adult Burn Patients: A Randomized Clinical Trial},
journal = {Journal of Burn Care & Research},
year = {2025},
doi = {10.1093/jbcr/irae158}
}
EUVIMED